Skip to main content

Table 1 Demographic and clinical data of HC, MS and NMO

From: Increased plasma levels of epithelial neutrophil-activating peptide 78/CXCL5 during the remission of Neuromyelitis optica

   HC (n = 20) MS (n = 25) NMO (n = 25)
Gender F/M 15/5 19/6 23/2
Age (year) Range 25–54 16–59 14–55
  Mean ± SE 32.30 ± 1.80 33.84 ± 2.31 36.80 ± 2.45
Age at onset (year) Range - 6–57 13–53
  Mean ± SE - 29.84 ± 2.28 30.24 ± 2.34
Disease duration (year) Range - 0–12 0–21
  Mean ± SE - 3.92 ± 0.53 6.04 ± 1.01
ARR Range - 0.35–12.00 0.01–12.00
  Mean ± SE - 1.61 ± 0.47 1.69 ± 0.47
EDSS Range - 0–3.5 1–6.5
  Mean ± SE - 1.92 ± 0.28 3.24 ± 0.35*
  1. HC healthy controls, MS multiple sclerosis, NMO Neuromyelitis optica, EDSS expanded disability status scale, ARR annual relapse rate
  2. *P < 0.05